REFERENCES
- Arnon S. S., Schechter R., Inglesby T. V., Henderson D. A., Bartlett J. G., Ascher M. S., Eitzen E., Fine A. D., Hauer J., Layton M., Lillibridge S., Osterholm M. T., O’Toole T., Parker G., Perl T. M., Russel P. K., Swerdlow D. L., Tonat K. Botulinum toxin as a biological weapon: medical and public health management. Journal of the American Medical Association 2001; 285(8)1059–1070
- Brigant J. L., Mallart A. Presynaptic currents in mouse motor endings. Journal of Physiology (London) 1982; 333: 619–636
- Burke D., Kiernan M. C., Bostock H. Excitability of human axons. Clinical Neurophysiology 2001; 112(9)1575–1585
- Cappelen-Smith C., Kuwabara S., Lin C. S.-Y., Mogyoros I., Burke D. Membrane properties in chronic inflammatory demyelinating polyneuropathy. Brain 2001; 124(Pt 12)2439–2447
- Gracies J. M. Physiological effects of botulinum toxin in spasticity. Movement Disorders 2004; 19(suppl 8)120–128
- Kanai K., Kuwabara S., Arai K., Sung J.-Y., Ogawara K., Hattori T. Muscle cramp in Machado–Joseph disease: Altered motor axonal excitability properties and mexiletine treatment. Brain 2003; 126(Pt 4)965–973
- Kiernan M. C., Burke D., Andersen K. V., Bostock H. Multiple measures of axonal excitability: A new approach in clinical testing. Muscle & Nerve 2000; 23(3)399–409
- Kiernan M. C., Hart I. K., Bostock H. Excitability properties of motor axons in patients with spontaneous motor unit activity. Journal of Neurology Neurosurgury & Psychiatry 2001a; 70(1)56–64
- Kiernan M. C., Lin C. S., Andersen K. V., Murray N. M., Bostock H. Clinical evaluation of excitability measures in sensory nerve. Muscle & Nerve 2001b; 24(7)883–892
- Kiernan M. C., Walters R. J. L., Andersen K. V., Taube D., Murray N. M. F., Bostock H. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalemia. Brain 2002; 125(Pt 6)1366–1378
- Krishnan A. V., Kiernan M. C. Axonal nerve excitability properties in established diabetic neuropathy. Brain 2005; 128(Pt 5)1178–1187
- Kuwabara S., Cappelen-Smith C., Lin S. Y. C., Mogyoros I., Bostock H., Burke D. Excitability properties of median and peroneal motor axons. Muscle & Nerve 2000; 23(9)1365–1373
- Martin C. O., Adams H. P., Jr. Neurological aspects of biological and chemical terrorism. Archive of Neurology 2003; 60(1)21–25
- Mogyoros I., Kiernan M. C., Burke D. Strength-duration properties of human peripheral nerve. Brain 1996; 119(Pt 2)439–447
- Nodera H., Bostock H., Kuwabara S., Sakamoto T., Asanuma K., Jia-Ying S., Ogawara K., Hattori N., Hirayama M., Sobue G., Kaji R. Nerve excitability properties in Charcot–Marie–Tooth disease type 1A. Brain 2004; 127(Pt 1)203–211
- Priori A., Cinnante C., Pesenti A., Carpo M., Cappellari A., Nobile-Orazio E., Scarlato G., Barbieri S. Distinctive abnormalities of motor axonal strength–duration properties in multifocal motor neuropathy and in motor neuron disease. Brain 2002; 125(Pt 11)2481–2490
- Shapiro R. L., Hatheway C., Swerdlow D. L. Botulism in the United States: A clinical and epidemiologic review. Annals of Internal Medicine 1998; 129(3)221–228
- Weiss G. Surla possibilité de rendle comparables entre eux les appareils servant à l’excitation électrique. Archives Italiennes de Biologie 1901; 35: 413–446
- Yerdelen D., Uysal H., Koc F., Sarica Y. Effects of sex and age on strength–duration properties. Clinical Neurophysiology 2006; 117(9)2069–2072